The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126130782 12613078 2 F 201607 20160810 20160802 20160814 EXP US-AMGEN-USASP2016097170 AMGEN 42.00 YR A F Y 99.79000 KG 20160814 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126130782 12613078 1 PS ENBREL ETANERCEPT 1 Subcutaneous 50 MG, QWK 103795 50 MG UNKNOWN FORMULATION /wk
126130782 12613078 2 SS LYRICA PREGABALIN 1 Unknown 150 MG, BID 0 150 MG CAPSULE BID
126130782 12613078 3 SS LYRICA PREGABALIN 1 Unknown 50 MG, BID 0 50 MG CAPSULE BID
126130782 12613078 4 SS LYRICA PREGABALIN 1 Unknown 75 MG, BID 0 75 MG CAPSULE BID
126130782 12613078 5 SS LYRICA PREGABALIN 1 Unknown 25 MG, UNK 0 25 MG CAPSULE
126130782 12613078 6 SS AUGMENTIN AMOXICILLINCLAVULANATE POTASSIUM 1 Oral 875 MG, UNK 0 875 MG BID
126130782 12613078 7 SS AUGMENTIN AMOXICILLINCLAVULANATE POTASSIUM 1 Unknown 500 MG, BID 0 500 MG BID
126130782 12613078 8 C MIRENA LEVONORGESTREL 1 Intra-uterine UNK 0
126130782 12613078 9 C MORPHINE MORPHINE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126130782 12613078 1 Ankylosing spondylitis
126130782 12613078 2 Product used for unknown indication
126130782 12613078 6 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126130782 12613078 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126130782 12613078 Arthralgia
126130782 12613078 Arthritis
126130782 12613078 Asthenia
126130782 12613078 Autoimmune thyroiditis
126130782 12613078 Blood chloride abnormal
126130782 12613078 Blood sodium decreased
126130782 12613078 Burning sensation
126130782 12613078 Carbon dioxide decreased
126130782 12613078 Chest discomfort
126130782 12613078 Chest pain
126130782 12613078 Conduction disorder
126130782 12613078 Dehydration
126130782 12613078 Dizziness
126130782 12613078 Dyspnoea
126130782 12613078 Feeling abnormal
126130782 12613078 Fibrin D dimer increased
126130782 12613078 Lichen sclerosus
126130782 12613078 Localised infection
126130782 12613078 Mental status changes
126130782 12613078 Migraine
126130782 12613078 Myofascial pain syndrome
126130782 12613078 Obesity
126130782 12613078 Orthostatic hypotension
126130782 12613078 Pain
126130782 12613078 Palpitations
126130782 12613078 Panic attack
126130782 12613078 Paraesthesia
126130782 12613078 Pyrexia
126130782 12613078 Tachyarrhythmia
126130782 12613078 Temporomandibular joint syndrome
126130782 12613078 Thyroid cancer
126130782 12613078 Vision blurred

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126130782 12613078 1 2013 0
126130782 12613078 2 201408 0
126130782 12613078 6 20160628 0